21 May 2013
Keywords: rituxan, gets, fda, approval, 1st-line, use, nhl
Article | 16 October 2006
US drug firms Genentech and Biogen Idec say that the co-marketed therapeutic antibody Rituxan (rituximab) has received Food and Drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 October 2006
20 November 2006
20 May 2013
© 2013 thepharmaletter.com